BioSpace News Archive

Activ Surgical, a pioneering digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility, today announced its ActivEdge platform

Customizable certification to restore public confidence; trust in protective measures launches nationwide

Cigna is launching its new COVID-19 Customer Protection Program to further safeguard its customers from unexpected costs for COVID-19 care through “surprise” or “balance” bills from out-of-network health care providers.

To meet the challenge of ensuring adequate food for the vulnerable senior population, whose needs have greatly increased due to the COVID-19 pandemic, Conviva Care Centers have stepped up to provide a donation of $2 million to support seven local Feeding America® member food banks in Florida and Texas.

NANOBIOTIX (Paris:NANO) (Euronext: NANO - ISIN: FR0011341205 – the “Company”), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that the protocol for the first trial from its clinical collaboration with The University of Texas MD Anderson Cancer Center (MD Anderson) has been designated as “safe to proceed” by the US Food and Drug Administration (FDA).

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced approval of ELYXYB (celecoxib oral solution 25 mg/mL) by the U.S. Food and Drug Administration (USFDA). ELYXYB (previously known as DFN-15) is indicated for the acute treatment of migraine with or without aura in adults.

AIkido Pharma Inc. (Nasdaq: AIKI) today announced execution of an Artificial Intelligence (AI), and Machine Learning (ML) research agreement with Cogia Biotech LTD (“Cogia”) (www.cogia.de) to accelerate the Company’s pancreatic cancer genetic marker research.

BGI Genomics announced today that its subsidiary BGI Americas Corporation has received authorization under Interim Order from Health Canada to supply its Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 in the Canadian market.

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Portola Pharmaceuticals, Inc. relating to the sale of the Company to Alexion Pharmaceuticals, Inc.

In an effort to fight the global COVID-19 pandemic, over 150 employees from clinical research and technology organizations have volunteered to support United Kingdom government COVID-19 testing centres.